WINTON GROUP Ltd Invests $209,000 in ZimVie Inc. (NASDAQ:ZIMV)

WINTON GROUP Ltd purchased a new position in ZimVie Inc. (NASDAQ:ZIMV) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 11,479 shares of the company’s stock, valued at approximately $209,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Cetera Advisors LLC bought a new position in ZimVie during the first quarter valued at approximately $2,615,000. CenterBook Partners LP bought a new position in ZimVie during the fourth quarter valued at approximately $988,000. Gabelli Funds LLC raised its position in ZimVie by 25.4% during the fourth quarter. Gabelli Funds LLC now owns 40,260 shares of the company’s stock valued at $715,000 after acquiring an additional 8,160 shares in the last quarter. Price T Rowe Associates Inc. MD raised its position in ZimVie by 6.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,531 shares of the company’s stock valued at $356,000 after acquiring an additional 1,275 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its position in ZimVie by 21.1% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 761,285 shares of the company’s stock valued at $13,513,000 after acquiring an additional 132,804 shares in the last quarter. Institutional investors own 95.63% of the company’s stock.

Insider Transactions at ZimVie

In related news, major shareholder Camber Capital Management Lp sold 525,000 shares of the business’s stock in a transaction on Friday, August 2nd. The shares were sold at an average price of $17.71, for a total transaction of $9,297,750.00. Following the transaction, the insider now owns 2,725,000 shares of the company’s stock, valued at $48,259,750. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 3.01% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Separately, Needham & Company LLC raised their price objective on shares of ZimVie from $20.00 to $23.00 and gave the company a “buy” rating in a research report on Friday, August 2nd.

ZimVie Price Performance

Shares of ZimVie stock opened at $16.47 on Thursday. The firm has a fifty day simple moving average of $18.25 and a 200-day simple moving average of $17.17. The company has a current ratio of 1.94, a quick ratio of 1.43 and a debt-to-equity ratio of 0.62. ZimVie Inc. has a 1-year low of $6.52 and a 1-year high of $22.40. The stock has a market capitalization of $454.08 million, a price-to-earnings ratio of -1.18 and a beta of 2.13.

ZimVie (NASDAQ:ZIMV) last issued its quarterly earnings data on Thursday, August 1st. The company reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.04). ZimVie had a positive return on equity of 2.21% and a negative net margin of 63.84%. The firm had revenue of $116.81 million during the quarter. During the same period last year, the firm earned $0.17 EPS. On average, sell-side analysts expect that ZimVie Inc. will post 0.63 earnings per share for the current year.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.